Archives: Agenda
Exploring GCC clinical research landscape
- Infrastructure Strengths of the UAE & GCC for Clinical Research
- UAE’s Precision Medicine and Genomics Ecosystem: A Global Benchmark
- Why the GCC is Emerging as the Next Global Hub for Clinical Trials
Chair’s closing remarks
From Pressure to Performance: 5 strategic steps to AI success
Registration and Refreshments
Morning Refreshments and Networking
PRIZE DRAW
Visit our exhibitors’ booths throughout the day and collect stamps in order to enter our Prize Draw and be in for a chance of winning Apple prizes or Amazon gift cards. The Prize Draw will take place in the Exhibition Hall. Make sure you don’t miss out!
Morning refreshments and networking
PANEL DISCUSSION: Accelerating Study Start-Up: Driving Operational Readiness and Trial Momentum for Faster Trial Launches
- Effectively championing adaptive trial designs to stay nimble as the clinical research landscape continues to evolve
- Streamlining protocol finalization, regulatory submissions, and feasibility assessments to shorten start-up timelines
- Identifying and engaging the right sites as part of a broader operational readiness strategy
- Coordinating cross-functional teams, vendor partnerships, and internal stakeholders to ensure smooth study initiation
- Implementing robust onboarding, training, and communication plans to set the trial up for success from day one
- Reducing contract cycle times to accelerate study start-up
Interactive Speaker-Hosted Breakfast Breakout Discussions
With drinks and refreshments, interactive breakout sessions offer a unique opportunity to come together with your peers to share best practice and develop solutions to critical challenges facing the industry as a whole. Each discussion will run twice and be led by a table moderator and will focus on a different challenge within clinical trials. Breakout discussions are an exciting, interactive way to build your personal network and learn from the experience and expertise of others.
| Discussion 1 | Turning Inspection Fears into Operational Readiness In An Uncertain Regulatory Environment
Hosted by Regina Griffin, Associate Director, Clinical Operations, Autobahn Therapeutics |
| Discussion 2 | Vendor Oversight – Whose Job Is It Anyways?
Hosted by Denise Deegan, Associate Director, Clinical Operations, Pionyr Immunotherapeutics |
| Discussion 3 | Conducting Clinical Trials in A Greener, Sustainable Way |
| Discussion 4 | How To Strategically Plan and Curb Risk As A Small Biotech |
| Discussion 5 | Finding The Right Balance with Digital Health Tools In Clinical Trials |